Furthermore, tumor size (>5 cm), presence of neural infiltration and vascular invasion, p53 overexpression, and high Ki67 proliferation index identify subsets of SS patients with increased risk of tumor relapse [42-44]. The gene discussed is TP53; the disease is synovial sarcoma.